http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TR-201819312-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffbe71cb54b92414ad178bb647126c1d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2018-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14eb4e5168bb14a6624fdff4df6e4355
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c09bbe6d645f0bff4acb44b0ec9e5cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8cd3281c287c02af79ea4cff0bc0dac
publicationDate 2019-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TR-201819312-A2
titleOfInvention DOUBLE LAYER TABLET FORMULATION OF FESOTHERODINE
abstract The present invention; It relates to a bilayer tablet formulation containing fesoterodine or a pharmaceutically acceptable salt of fesoterodine.
priorityDate 2017-12-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918558
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419479800

Total number of triples: 23.